Equidam
Depends
Confidence: Medium
Buy if you are a startup, accelerator, or advisor needing a fast, benchmark-backed valuation report with pay-per-use pricing.
New check
Comparison
Equidam lands on Depends, and Eqvista lands on Worth it.
Buy if you are a startup, accelerator, or advisor needing a fast, benchmark-backed valuation report with pay-per-use pricing.
Buy if you're a startup needing a cap table plus 409A valuations and want Carta-class features for less.
| Compare | Equidam | Eqvista |
|---|---|---|
| Verdict | Depends | Worth it |
| Best for | Startups preparing to raise | VC-backed startups tracking option pools |
| Who it's not for | Buyers needing legally defensible, audit-grade valuations | Solo founders with no equity issued |
| Privacy | Published product security page exists; 219 credentials tied to appear in infostealer logs . not a confirmed breach.11 | No known public vulnerabilities found in the sources reviewed. |
| Support quality | No independent support evidence found | Admits high inquiry volume; slowdowns likely |
| Public sentiment | Users call it a useful, fast valuation tool, but independent review volume is small and ratings modest.⁷ | Review snippets are mostly truncated, but available ones praise 409A value and quick turnaround.16 |
| Biggest gotcha | Not a subscription: one-time fees, access days, and conditional refund rules⁵ | Post-Pulley surge may stretch the promised 3-5 day migration |